{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:14:23Z","timestamp":1771931663699,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100018764","name":"Semnan University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["95-1-101-30-31780"],"award-info":[{"award-number":["95-1-101-30-31780"]}],"id":[{"id":"10.13039\/501100018764","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s43032-023-01249-1","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T16:57:48Z","timestamp":1683824268000},"page":"3037-3045","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Adjuvant Treatment with Oral Dydrogesterone in the Prevention of Preterm Labor: A Randomized, Double-Blinded, Placebo-Controlled Trial"],"prefix":"10.1007","volume":"30","author":[{"given":"Hengameh","family":"Keshtmandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Mirmohammadkhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4842-9327","authenticated-orcid":false,"given":"Mojgan","family":"Rahmanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,11]]},"reference":[{"issue":"6","key":"1249_CR1","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1517\/14656566.2014.889684","volume":"15","author":"EO Van Vliet","year":"2014","unstructured":"Van Vliet EO, Boormans EM, De Lange TS, Mol BW, Oudijk MA. Preterm labor: current pharmacotherapy options for tocolysis. Expert Opin Pharmacother. 2014;15(6):787\u201397.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"1249_CR2","first-page":"75","volume":"11","author":"M Gharehgozloei","year":"2021","unstructured":"Gharehgozloei M, Mirmohammadkhani M, Rahmanian M. Evaluation of the effect of low dose aspirin on cervical length as an indicator of preterm labor in nulliparous women. J Chem Health Risks. 2021;11(1):75\u201384.","journal-title":"J Chem Health Risks"},{"issue":"1","key":"1249_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1471-2393-10-S1-S1","volume":"10","author":"JE Lawn","year":"2010","unstructured":"Lawn JE, Gravett MG, Nunes TM, Rubens CE, Stanton C, the GRG,. Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data. BMC Pregnancy Childbirth. 2010;10(1):S1.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1249_CR4","doi-asserted-by":"publisher","first-page":"649749","DOI":"10.3389\/fneur.2021.649749","volume":"12","author":"X Chen","year":"2021","unstructured":"Chen X, Zhang X, Li W, Li W, Wang Y, Zhang S, et al. Iatrogenic vs. spontaneous preterm birth: a retrospective study of neonatal outcome among very preterm infants. Front Neurol. 2021;12:649749.","journal-title":"Front Neurol"},{"issue":"1","key":"1249_CR5","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12884-018-1957-0","volume":"18","author":"AT Deressa","year":"2018","unstructured":"Deressa AT, Cherie A, Belihu TM, Tasisa GG. Factors associated with spontaneous preterm birth in Addis Ababa public hospitals, Ethiopia: cross sectional study. BMC Pregnancy Childbirth. 2018;18(1):332.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"1249_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep20638","volume":"6","author":"W Areeruk","year":"2016","unstructured":"Areeruk W, Phupong V. A randomized, double blinded, placebo controlled trial of oral dydrogesterone supplementation in the management of preterm labor. Sci Rep. 2016;6(1):1\u20136.","journal-title":"Sci Rep"},{"issue":"2","key":"1249_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.siny.2015.12.007","volume":"21","author":"MS Harrison","year":"2016","unstructured":"Harrison MS, Goldenberg RL. Global burden of prematurity. Semin Fetal Neonatal Med. 2016;21(2):74\u20139.","journal-title":"Semin Fetal Neonatal Med"},{"issue":"4","key":"1249_CR8","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/dmcn.13675","volume":"60","author":"A Pascal","year":"2018","unstructured":"Pascal A, Govaert P, Oostra A, Naulaers G, Ortibus E, Van den Broeck C. Neurodevelopmental outcome in very preterm and very-low-birthweight infants born over the past decade: a meta-analytic review. Dev Med Child Neurol. 2018;60(4):342\u201355.","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"1249_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1447-0756.2007.00623.x","volume":"33","author":"S Borna","year":"2007","unstructured":"Borna S, Saeidi FM. Celecoxib versus magnesium sulfate to arrest preterm labor: randomized trial. J Obstet Gynaecol Res. 2007;33(5):631\u20134.","journal-title":"J Obstet Gynaecol Res"},{"issue":"5","key":"1249_CR10","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3109\/14767058.2015.1021671","volume":"29","author":"A Theplib","year":"2016","unstructured":"Theplib A, Phupong V. Success rate of terbutaline in inhibiting preterm labor for 48 h. J Maternal-fetal Neonatal Med\u202f: Off J Eur Assoc Perinatal Med Fed Asia Oceania Perinatal Soc Int Soc Perinatal Obstet. 2016;29(5):841\u20134.","journal-title":"J Maternal-fetal Neonatal Med : Off J Eur Assoc Perinatal Med Fed Asia Oceania Perinatal Soc Int Soc Perinatal Obstet"},{"issue":"8","key":"1249_CR11","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/pd.5923","volume":"41","author":"L Lehoczky","year":"2021","unstructured":"Lehoczky L, Southworth AB, ZamudioMart\u00ednez G, Belfort MA, Shamshirsaz AA, Shamshirsaz A, et al. Magnesium sulfate titration reduces maternal complications following fetoscopic closure of spina bifida. Prenat Diagn. 2021;41(8):983\u20138.","journal-title":"Prenat Diagn"},{"key":"1249_CR12","doi-asserted-by":"crossref","unstructured":"Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev. 2002;(4):CD001060.","DOI":"10.1002\/14651858.CD001060"},{"issue":"7","key":"1249_CR13","first-page":"444","volume":"91","author":"DA Seehusen","year":"2015","unstructured":"Seehusen DA, Grogan SP. Magnesium sulfate for prevention of preterm birth. Am Fam Physician. 2015;91(7):444\u20135.","journal-title":"Am Fam Physician"},{"issue":"2","key":"1249_CR14","first-page":"60","volume":"4","author":"ER Norwitz","year":"2011","unstructured":"Norwitz ER, Caughey AB. Progesterone supplementation and the prevention of preterm birth. Rev Obstet Gynecol. 2011;4(2):60\u201372.","journal-title":"Rev Obstet Gynecol"},{"issue":"3","key":"1249_CR15","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3390\/ijms23031333","volume":"23","author":"R Raghupathy","year":"2022","unstructured":"Raghupathy R, Szekeres-Bartho J. Progesterone: A unique hormone with immunomodulatory roles in pregnancy. Int J Mol Sci. 2022;23(3):1333.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1249_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jsbmb.2005.08.013","volume":"97","author":"M Omar","year":"2005","unstructured":"Omar M, Mashita M, Lim P, Jamil M. Dydrogesterone in threatened abortion: pregnancy outcome. J Steroid Biochem Mol Biol. 2005;97(5):421\u20135.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"1249_CR17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3109\/09513590.2015.1115832","volume":"32","author":"N Podzolkova","year":"2016","unstructured":"Podzolkova N, Tatarchuk T, Doshchanova A, Eshimbetova G, Pexman-Fieth C. Dydrogesterone treatment for menstrual-cycle regularization in routine clinical practice: a multicenter observational study. Gynecol Endocrinol\u202f: Off J Int Soc Gynecol Endocrinol. 2016;32(3):246\u20139.","journal-title":"Gynecol Endocrinol : Off J Int Soc Gynecol Endocrinol"},{"issue":"2","key":"1249_CR18","first-page":"143","volume":"42","author":"HJ Carp","year":"2021","unstructured":"Carp HJ. Progestogens in luteal support. Horm Mol Biol Clin Invest. 2021;42(2):143\u20138.","journal-title":"Horm Mol Biol Clin Invest"},{"key":"1249_CR19","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1016\/j.maturitas.2009.09.013","volume":"65","author":"AO Mueck","year":"2009","unstructured":"Mueck AO, Seeger H, B\u00fchling K-J. Use of dydrogesterone in hormone replacement therapy. Maturitas. 2009;65:S51\u201360.","journal-title":"Maturitas"},{"issue":"Suppl 1","key":"1249_CR20","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","volume":"46","author":"AE Schindler","year":"2003","unstructured":"Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, et al. Classification and pharmacology of progestins. Maturitas. 2003;46(Suppl 1):S7-s16.","journal-title":"Maturitas"},{"issue":"1","key":"1249_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12884-022-04509-1","volume":"22","author":"F Alizadeh","year":"2022","unstructured":"Alizadeh F, Mahmoudinia M, Mirteimoori M, Pourali L, Niroumand S. BMC Pregnancy Childbirth. 2022;22(1):167.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"1249_CR22","first-page":"15","volume":"2","author":"S Marzano","year":"2008","unstructured":"Marzano S, Padula F, Meloni P, Anceschi MM. Preterm delivery at low gestational age: risk factors for short latency. A multivariated analysis. J Prenat Med. 2008;2(2):15\u20138.","journal-title":"J Prenat Med"},{"key":"1249_CR23","doi-asserted-by":"publisher","first-page":"20638","DOI":"10.1038\/srep20638","volume":"6","author":"W Areeruk","year":"2016","unstructured":"Areeruk W, Phupong V. A randomized, double blinded, placebo controlled trial of oral dydrogesterone supplementation in the management of preterm labor. Sci Rep. 2016;6:20638.","journal-title":"Sci Rep"},{"issue":"1","key":"1249_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1479-828X.2007.00803.x","volume":"48","author":"S Borna","year":"2008","unstructured":"Borna S, Sahabi N. Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial. Aust N Z J Obstet Gynaecol. 2008;48(1):58\u201363.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"12","key":"1249_CR25","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1111\/jog.13128","volume":"42","author":"EY Jung","year":"2016","unstructured":"Jung EY, Oh KJ, Hong JS, Han BR, Joo JK. Addition of adjuvant progesterone to physical-exam-indicated cervical cerclage to prevent preterm birth. J Obstet Gynaecol Res. 2016;42(12):1666\u201372.","journal-title":"J Obstet Gynaecol Res"},{"issue":"19","key":"1249_CR26","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.3390\/jcm10194511","volume":"10","author":"GC Di Renzo","year":"2021","unstructured":"Di Renzo GC, Tosto V, Tsibizova V, Fonseca E. Prevention of preterm birth with progesterone. J Clin Med. 2021;10(19):4511.","journal-title":"J Clin Med"},{"issue":"5","key":"1249_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.5468\/ogs.2017.60.5.405","volume":"60","author":"S-J Choi","year":"2017","unstructured":"Choi S-J. Use of progesterone supplement therapy for prevention of preterm birth: review of literatures. Obstet Gynecol Sci. 2017;60(5):405\u201320.","journal-title":"Obstet Gynecol Sci"},{"issue":"8","key":"1249_CR28","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1177\/1933719111398150","volume":"18","author":"MS Soloff","year":"2011","unstructured":"Soloff MS, Jeng Y-J, Izban MG, Sinha M, Luxon BA, Stamnes SJ, et al. Effects of progesterone treatment on expression of genes involved in uterine quiescence. Reprod Sci. 2011;18(8):781\u201397.","journal-title":"Reprod Sci"},{"key":"1249_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.placenta.2019.01.018","volume":"79","author":"SA Mesiano","year":"2019","unstructured":"Mesiano SA, Peters GA, Amini P, Wilson RA, Tochtrop GP, van Den Akker F. Progestin therapy to prevent preterm birth: history and effectiveness of current strategies and development of novel approaches. Placenta. 2019;79:46\u201352.","journal-title":"Placenta"},{"issue":"6","key":"1249_CR30","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/j.ajog.2007.10.013","volume":"197","author":"N Ruddock","year":"2007","unstructured":"Ruddock N, Shi S-Q, Jain S, Moore G, Hankins GD, Romero R, et al. 11: Progesterone (P4), but not 17alpha hydroxyprogesterone caproate (17P), inhibits human myometrial contractions. Am J Obstet Gynecol. 2007;197(6):S6.","journal-title":"Am J Obstet Gynecol"},{"key":"1249_CR31","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.lfs.2018.07.004","volume":"207","author":"K Yasuda","year":"2018","unstructured":"Yasuda K, Sumi G-I, Murata H, Kida N, Kido T, Okada H. The steroid hormone dydrogesterone inhibits myometrial contraction independently of the progesterone\/progesterone receptor pathway. Life Sci. 2018;207:508\u201315.","journal-title":"Life Sci"},{"issue":"3","key":"1249_CR32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0028-2243(91)90118-5","volume":"40","author":"G Noblot","year":"1991","unstructured":"Noblot G, Audra P, Dargent D, Faguer B, Mellier G. The use of micronized progesterone in the treatment of menace of preterm delivery. Eur J Obstet Gynecol Reprod Biol. 1991;40(3):203\u20139.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"1249_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijgo.2015.06.058","volume":"132","author":"AC Eke","year":"2016","unstructured":"Eke AC, Chalaan T, Shukr G, Eleje GU, Okafor CI. A systematic review and meta-analysis of progestogen use for maintenance tocolysis after preterm labor in women with intact membranes. Int J Gynecol Obstet. 2016;132(1):11\u20136.","journal-title":"Int J Gynecol Obstet"},{"issue":"1","key":"1249_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12884-021-03562-6","volume":"21","author":"S Thongchan","year":"2021","unstructured":"Thongchan S, Phupong V. Oral dydrogesterone as an adjunctive therapy in the management of preterm labor: a randomized, double blinded, placebo-controlled trial. BMC Pregnancy Childbirth. 2021;21(1):1\u20137.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"1249_CR35","first-page":"21","volume":"8","author":"S Gupta","year":"2012","unstructured":"Gupta S, Roman AS. 17-\u03b1 hydroxyprogesterone caproate for the prevention of preterm birth. Women\u2019s Health. 2012;8(1):21\u201330.","journal-title":"Women\u2019s Health"},{"key":"1249_CR36","doi-asserted-by":"crossref","unstructured":"Arikan I, Barut A, Harma M, Harma IM. Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor. Gynecol Obstet Invest. 2011;72(4):269\u201373.","DOI":"10.1159\/000328719"},{"key":"1249_CR37","doi-asserted-by":"crossref","unstructured":"Borna S, Sahabi N. Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial. Aust N Z J Obstet Gynaecol. 2008;48(1):58\u201363","DOI":"10.1111\/j.1479-828X.2007.00803.x"},{"key":"1249_CR38","doi-asserted-by":"crossref","unstructured":"Choudhary M, Suneja A, Vaid NB, Guleria K, Faridi MM. Maintenance tocolysis with oral micronized progesterone for prevention of preterm birth after arrested preterm labor. Int J Gynaecol Obstet. 2014;126(1):60\u20133.","DOI":"10.1016\/j.ijgo.2014.01.019"},{"key":"1249_CR39","doi-asserted-by":"crossref","unstructured":"Wood S, Rabi Y, Tang S, Brant R, Ross S. Progesterone in women with arrested premature labor, a report of a randomised clinical trial and updated meta-analysis. BMC Pregnancy Childbirth. 2017;17(1):258.","DOI":"10.1186\/s12884-017-1400-y"},{"issue":"14","key":"1249_CR40","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1080\/14767058.2017.1330406","volume":"31","author":"O Pustotina","year":"2018","unstructured":"Pustotina O. Effectiveness of dydrogesterone, 17-OH progesterone and micronized progesterone in prevention of preterm birth in women with a short cervix. J Matern Fetal Neonatal Med. 2018;31(14):1830\u20138.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"7","key":"1249_CR41","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3109\/14767058.2011.629014","volume":"25","author":"DA Bomba-Opon","year":"2012","unstructured":"Bomba-Opon DA, Kosinska-Kaczynska K, Kosinski P, Wegrzyn P, Kaczynski B, Wielgos M. Vaginal progesterone after tocolytic therapy in threatened preterm labor. J Matern Fetal Neonatal Med. 2012;25(7):1156\u20139.","journal-title":"J Matern Fetal Neonatal Med"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-023-01249-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-023-01249-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-023-01249-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T17:17:12Z","timestamp":1696526232000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-023-01249-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1249"],"URL":"https:\/\/doi.org\/10.1007\/s43032-023-01249-1","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,11]]},"assertion":[{"value":"2 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of the Semnan University of Medical Sciences with the approval code of IR.SEMUMS.REC.1397.199.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval (Include Appropriate Approvals or Waivers)"}},{"value":"The written informed consent form was signed by all potential subjects signed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate (Include Appropriate Statements)"}},{"value":"The written informed consent form was signed by all potential subjects signed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication (Include Appropriate Statements)"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}